{
}
The French government has secured strong guarantees in the sale of a 50% stake in Opella, producer of Doliprane, to American investment fund CD & R, which aims to enhance growth. The agreement includes a €70 million investment in France, job protection, and penalties for production stoppages. Sanofi retains a 48% stake, ensuring continued involvement in Opella's operations.
SPIE SA
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
French government secures guarantees in sale of Doliprane to US fund
Euro
Rexel S.A.
SPIE SA
Seqens
Sanofi
CD & R
USA
CHN
FRA
Marc Ferracci
Nicolas Dufourcq
Paul Hudson
Antoine Armand
Show more
11:05 21.10.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Industry Trends
Global Trade Developments
Stock Market Updates
Supply Chain Management
Industry Mergers & Acquisitions
Retail and Consumer Goods
Fintech Startups
Private Equity Deals
Government Economic Policies
Venture Capital Investments
Inflation and Monetary Impact
CEO Changes
Central Bank Actions
Workplace Trends
Corporate Social Responsibility
Finance Mergers & Acquisitions
Economic Indicators
AI Innovations
Countries:
Companies:
Apple Inc.
Google Inc.
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Delhivery Limited
Ecom Express Ltd.
EFG Hermes Egypt
NIO Inc.
Morgan Stanley
Nikkei 225
Nintendo Co., Ltd.
Goto Ltd
Mizuho Financial Group, Inc.
Mitsubishi UFJ Financial Group, Inc.
Microsoft Corporation
Scripbox.COM India Ltd.
Amazon.com, Inc.
OpenAI ERC USD
JPMorgan Chase & Co.
Eurasia Groupe SA
Currencies:
United States Dollar
Indian Rupee
Euro
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
South Korean Won
Indonesian Rupiah
Saudi Riyal
Hong Kong Dollar
New Taiwan Dollar
Offshore Chinese Yuan
Egyptian Pound
Pakistani Rupee
Qatari Riyal
Malaysian Ringgit
Filipino Peso
West African CFA Franc
Thai Baht
Mexican Peso
People: